Compare Ross Stores, Inc. (ROST) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ross Stores, Inc. vs Recursion Pharmaceuticals Inc — how do they compare? Ross Stores, Inc. trades at $235 (market cap $75.63B), while Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B). The key difference: Ross Stores, Inc. is far larger — about 49.4× Recursion Pharmaceuticals Inc's market cap, and Ross Stores, Inc. pays a 0.75% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| ROST | RXRX | |
|---|---|---|
Market Cap | $75.63B | $1.53B |
Sector | Consumer Cyclical | Health |
52-Week High | $240.13 | $6.79 |
52-Week Low | $134.02 | $2.84 |
Enterprise Value | $76.23B | $946.50M |
Dividend Yield | 0.75% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
